IMA Q1 2026 Earnings Missed EPS Estimates Amid Continued Pipeline Development Reviva Pharmaceuticals RVPH Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Discipline Amid PreRevenue Stage MicroVision Q1 2026 Earnings EPS Misses Estimates Stock Rises Despite Revenue Absence BridgeBio Oncology Therapeutics Inc BBOT Q1 2026 Earnings NarrowerThanExpected Loss Fails to Stem Stock Slide EDUC Q1 2026 Earnings Narrowing Loss Highlights Ongoing Restructuring INTT Q1 2026 Earnings Strong EPS Beat Driven by Operational Execution